Lupin gets 2 observations from USFDA for Nagpur facility Medical Dialogues Bureau13 Jan 2020 6:28 AM GMTDrug firm Lupin on Saturday said it has received two observations from the US health regulator following the inspection of its Nagpur manufacturing...
Dr Reddy's gets EIR for Vizag plant, but inspection not closed Ruby Khatun Khatun22 Nov 2017 5:36 AM GMTNew Delhi: Dr. Reddy's Laboratories said it has received an establishment inspection report (EIR) from the US health regulator for its formulation...
Mylan seeks EMA approval for 2 biosimilars Ruby Khatun Khatun9 Nov 2017 5:02 AM GMTNew Delhi: Biocon said that its partner Mylan has re-submitted marketing authorization applications with the European Medicines Agency for two...
Divis Labs gets 6 USFDA observations for Vizag unit Ruby Khatun Khatun21 Sep 2017 4:57 AM GMTNew Delhi: Drug firm Divis Laboratories on Thursday said it has received six new observations from the US Food and Drug Administration (USFDA) after...
Dr Reddys Vizag unit gets 6 observations by German regulator Ruby Khatun Khatun9 Sep 2017 4:02 AM GMTNew Delhi: Dr Reddy's Laboratories (DRL) said the German drug regulator has concluded the audit of its Visakhapatnam formulations facility with six...